Clin2
NCT06995651Possibly a fitRecruiting

Dorzagliatin for blood sugar in cystic fibrosis

Pancreatic InsufficiencyCystic Fibrosis-related Diabetes

Treatments studied

Part of Digestive system clinical trials.

This study tests a drug called dorzagliatin to see if it can help control blood sugar in adults with cystic fibrosis who have pancreatic insufficiency and abnormal glucose tolerance.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
15 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have a confirmed diagnosis of cystic fibrosis.
  • Your pancreas does not work well, so you take enzyme pills with meals.
  • You have been told you have abnormal glucose tolerance or cystic fibrosis related diabetes.
  • You are 18 years old or older.
  • For women who can get pregnant: you are willing to use effective birth control (like birth control pills, IUD, or barrier methods with spermicide).
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT01851694Recruiting
Study incretin hormone response in adults with cystic fibrosis

This study tests how the body’s “incretin” hormones affect insulin (sugar control) in adults with cystic fibrosis and certain blood sugar patterns. It may help explain what drives diabetes risk in cystic fibrosis and how the body responds to these hormone signals.

Philadelphia, Pennsylvania
NCT04731272Recruiting· Phase 2
Weekly GLP-1 medicine for blood sugar issues in adults with CF

This Phase 2 trial tests a weekly GLP-1 medicine (dulaglutide) to improve blood sugar control in adults with cystic fibrosis (CF) who have trouble managing glucose. It may help people with CF-related prediabetes or diabetes by improving how their body handles sugar.

Aurora, Colorado
NCT07102043Enrolling by invitation
Glucose study in cystic fibrosis related diabetes

This study looks at how the body handles sugar in people with cystic fibrosis related diabetes. Researchers want to learn more about glucose metabolism to improve care for people with CFRD.

Birmingham, Alabama
NCT05723445Recruiting
Low glycemic diet test for diabetes and body changes in CF

This trial studies whether a low glycemic load (a specific way of choosing carbohydrates) improves blood sugar control and body composition in adults with cystic fibrosis–related diabetes. It may help reduce blood sugar problems and support healthier weight and body measurements.

Boston, Massachusetts
NCT07688070Not yet recruiting· Phase 2
Verapamil for blood sugar issues in cystic fibrosis

This trial tests if Verapamil, a blood pressure medication, can help improve blood sugar control in people with cystic fibrosis who have early diabetes or abnormal glucose tolerance. It may offer a new way to manage these issues.

Boston, Massachusetts
NCT05766774Recruiting
Diet study for adults with cystic fibrosis and high sugar intake

This trial studies whether changing eating habits—especially added sugar intake—affects health in adults with cystic fibrosis. It may help by testing a diet approach aimed at better outcomes related to metabolism and overall health.

Atlanta, Georgia

Hear when a new Pancreatic Insufficiency trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.